Wei Lü

14.3k citations
175 papers · 12.6k · 5 hit papers · h-index 55

Impact in

Papers in

Wei Lü

173 papers receiving 12.3k citations

Wei Lü's Hit Papers

ALKBH5-mediated m6A modification of IL-11 drives macrophage-to-myofibroblast transition and pathological cardiac fibrosis in mice 2024 · 87 citations
870+5+11Years since publication200400600

Peers

Wei Lü
Comparison fields: 5 of 147
  • Biomaterials 2.9k
  • Pharmaceutical Science 808
  • Biomedical Engineering 3.6k
  • Neurology 562
  • Drug Discovery 17
Replace Yunfeng Lin with:
Yunfeng Lin China
Dušica Maysinger Canada
Stefaan J. Soenen Belgium
Daniel Scherman France
Jin Keun Chang China
Seulki Lee South Korea
Zhiqing Pang China
Xueqing Wang China
Madhavan Nair United States
Jianqing Gao China
Wei Lü relative to Yunfeng Lin China Yunfeng Lin's profile →
Citations per field
00.5×2×3.1×
Yunfeng Lin · 1×
Citations per year

Countries citing papers authored by Wei Lü

Since Specialization
Citations

This map shows the geographic impact of Wei Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lü more than expected).

Fields of papers citing papers by Wei Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lü. The network helps show where Wei Lü may publish in the future.

Co-authors

The 25 scholars most cited alongside Wei Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei Lü Line = papers co-authored together Wei Lü links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 175 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Chelator-Free Multifunctional [64Cu]CuS Nanoparticle Platform for Simultaneous Micro-PET/CT Imaging and Photothermal Ablation Therapy
Hit paper breakdown →
2010675
2
Copper Sulfide Nanoparticles for Photothermal Ablation of Tumor Cells
Hit paper breakdown →
2010594
3
Subunit Composition of Synaptic AMPA Receptors Revealed by a Single-Cell Genetic Approach
Hit paper breakdown →
2009547
4
Combinatorial Photothermal and Immuno Cancer Therapy Using Chitosan-Coated Hollow Copper Sulfide Nanoparticles
Hit paper breakdown →
2014507
5 2009506
6 2008356
7 2012338
8 2008321
9 2014315
10 2013297
11 2009292
12 2019288
13 2005280
14 2009276
15 2004264
16 2006260
17 2010248
18 2008225
19 2006199
20 2011182

About Wei Lü

Wei Lü is a scholar working on Biomaterials, Biomedical Engineering, Pharmaceutical Science, Immunology and Neurology, having authored 175 papers that have together received 12.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (33 papers), Nanoparticle-Based Drug Delivery (27 papers), Advanced Drug Delivery Systems (10 papers), Gold and Silver Nanoparticles Synthesis and Applications (8 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Bone Tissue Engineering Materials (6 papers), Photodynamic Therapy Research Studies (6 papers) and Barrier Structure and Function Studies (6 papers). The work is most often cited by research in Biomaterials (2.9k citations), Pharmaceutical Science (808 citations), Biomedical Engineering (3.6k citations), Neurology (562 citations) and Drug Discovery (17 citations). Wei Lü has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xinguo Jiang, Chun Li, Qian Huang, Qizhi Zhang, Marites Pasuelo Melancon, Rui Zhang, Kaili Hu, Liangran Guo, Shaoli Song and Mei Tian. Their work appears in journals such as Journal of Controlled Release, Biomaterials, ACS Nano, Pharmaceutics and International Journal of Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact